AU2001270209A1 - Hiv-1 vaccines and screening methods therefor - Google Patents
Hiv-1 vaccines and screening methods thereforInfo
- Publication number
- AU2001270209A1 AU2001270209A1 AU2001270209A AU7020901A AU2001270209A1 AU 2001270209 A1 AU2001270209 A1 AU 2001270209A1 AU 2001270209 A AU2001270209 A AU 2001270209A AU 7020901 A AU7020901 A AU 7020901A AU 2001270209 A1 AU2001270209 A1 AU 2001270209A1
- Authority
- AU
- Australia
- Prior art keywords
- vaccines
- hiv
- screening methods
- methods therefor
- therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21460800P | 2000-06-27 | 2000-06-27 | |
US60/214,608 | 2000-06-27 | ||
US09/891,609 US20020127238A1 (en) | 2000-06-27 | 2001-06-26 | HIV-1 vaccines and screening methods therefor |
US09/891,609 | 2001-06-26 | ||
PCT/US2001/020483 WO2002000250A2 (en) | 2000-06-27 | 2001-06-27 | Hiv-1 vaccines and screening methods therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001270209A1 true AU2001270209A1 (en) | 2002-01-08 |
Family
ID=26909175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001270209A Abandoned AU2001270209A1 (en) | 2000-06-27 | 2001-06-27 | Hiv-1 vaccines and screening methods therefor |
Country Status (5)
Country | Link |
---|---|
US (1) | US20020127238A1 (ja) |
EP (1) | EP1296712A2 (ja) |
JP (1) | JP2004520262A (ja) |
AU (1) | AU2001270209A1 (ja) |
WO (1) | WO2002000250A2 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003237528A1 (en) | 2002-06-07 | 2003-12-22 | Kentucky Bioprocessing, Llc | Flexible vaccine assembly and vaccine delivery platform |
US7622125B2 (en) | 2004-05-05 | 2009-11-24 | Novartis Vaccines And Diagnostics, Inc. | Polycistronic HIV vector constructs |
WO2010042760A2 (en) * | 2008-10-08 | 2010-04-15 | The Administrators Of The Tulane Educational Fund | Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens |
WO2010041942A1 (en) * | 2008-10-08 | 2010-04-15 | Academisch Medisch Centrum Bij De Universiteit Van Amsterdam | Improved env peptides and proteins |
-
2001
- 2001-06-26 US US09/891,609 patent/US20020127238A1/en not_active Abandoned
- 2001-06-27 AU AU2001270209A patent/AU2001270209A1/en not_active Abandoned
- 2001-06-27 EP EP01948773A patent/EP1296712A2/en not_active Withdrawn
- 2001-06-27 WO PCT/US2001/020483 patent/WO2002000250A2/en not_active Application Discontinuation
- 2001-06-27 JP JP2002505031A patent/JP2004520262A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2002000250A2 (en) | 2002-01-03 |
WO2002000250A3 (en) | 2002-10-31 |
US20020127238A1 (en) | 2002-09-12 |
JP2004520262A (ja) | 2004-07-08 |
EP1296712A2 (en) | 2003-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001275441A1 (en) | Filter arrangement and methods | |
AU2002352903A1 (en) | Mesoporous materials and methods | |
AU2002314433A1 (en) | Ephrin-tie receptor materials and methods | |
AU2001280599A1 (en) | Compounds and methods | |
AU2002239740A1 (en) | Nanolithography methods and products therefor and produced thereby | |
AU2001253418A1 (en) | Compounds and methods | |
AU2002211183A1 (en) | Prosthetic construct and methods for its manufacture and use | |
AU2001243394A1 (en) | Compounds and methods | |
AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
AU2001296709A1 (en) | Gemstone | |
AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
AUPQ872300A0 (en) | Compounds and methods | |
AU2001238196A1 (en) | Multi-mode audiometric device and associated screening method | |
AU2001278951A1 (en) | Compounds and methods | |
AU2001266176A1 (en) | Methods | |
AU2001270209A1 (en) | Hiv-1 vaccines and screening methods therefor | |
AU2002341828A1 (en) | Enhanced proteins and methods for their use | |
AU2002256556A1 (en) | Sea-trosy and related methods | |
AU2002235277A1 (en) | Compounds and methods | |
AU2001261534A1 (en) | The meca-79 antigen and related methods | |
AU2001250536A1 (en) | Methods | |
AU2001284215A1 (en) | Methods | |
AU4667801A (en) | Methods | |
AU2002221222A1 (en) | Novel method and use | |
AU2001253715A1 (en) | Ceramic supports and methods |